Natural Biocon (India) Ltd
₹2.08▼ -0.04 (-1.89%)
NATURAL·BSE·Healthcare
Market Cap
5.31 Cr
PE Ratio
-50.30
Volume
75,471
Day High - Low
2.19 - 2.02
52W High-Low
6.38 - 2.02
₹2.08▼ -0.04 (-1.89%)
Market Cap5.31 Cr
PE Ratio-50.30
Volume75,471
Day High - Low2.19 - 2.02
52W High-Low6.38 - 2.02
Natural Biocon (India) Ltd (NATURAL): company summary
The company's business has deteriorated significantly, with annual revenue falling 69.6% to ₹3 crore and annual net profit swinging from a profit of ₹0 crore to a loss of ₹0 crore.
Natural Biocon (India) Ltd (NATURAL) is a micro-cap Healthcare company valued at ₹5 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Natural Biocon (India) Ltd last traded at ₹2.08, modestly down 1.89% on the day.
- Financial performance
- The company's business has deteriorated significantly, with annual revenue falling 69.6% to ₹3 crore and annual net profit swinging from a profit of ₹0 crore to a loss of ₹0 crore. The latest quarter showed revenue collapsing 100.0% to ₹0 crore, while net profit remained at a loss of ₹0 crore.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 0.30 times book value.
- Things to watch
- The company has reported a net loss of ₹0 crore in its latest financial year, and the latest quarter showed no revenue. The net profit margin has plunged 2.1 percentage points to -1.6%, and return on equity remains at -0.1%. The stock is 66.8% below its 52-week high, and the company's market cap is ₹5 crore.
- Where it stands
- Natural Biocon (India) Ltd has reported a net loss of ₹0 crore in its latest financial year, with the latest quarter showing no revenue. The stock is 66.8% below its 52-week high, and the company's market cap is ₹5 crore.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
4.6/10
Weak
Fair Value
Sign in to see
ROE
-0.13%
Weak
P/E
-50.30x
Loss-making
Debt / Equity
0.01
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed
Price performance
Day₹2.02
₹2.19
52W₹2.02
₹6.38
DocStoX take
Supported by growth (7.5) and risk (6.3), but held back by momentum (0.0). Growth looks strong at 7.5, but that is offset by momentum at 0.0 and quality at 2.5. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence4.6
/10
Weak
Quality
Weak
ROE -0.1%
Valuation
Fair
P/B 0.3× on assets (no earnings to value)
Growth
Strong
Revenue +81.2% 5Y CAGR
Risk
Moderate
D/E 0.01
Momentum
Weak
1% of 52-week range
At a glance
Market Cap
₹5 Cr
52W High / Low
₹6 / ₹2
Dividend Yield
0.00%
Promoter Holding
9.36%
EPS (TTM)
₹-0.02
Book Value
₹11.92
Key highlights
- Revenue compounding 81% a year
- Low leverage — D/E 0.01
- Loss-making — no meaningful P/E
- Momentum is weak (0.0/10)
2 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Natural Biocon (India) Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Natural Biocon (India) Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LLAURUS LABS LIMITEDZYDUS LIFESCIENCES LTDAPOLLO HOSPITALS ENTER. LCIPLA LTDDR. REDDY S LABORATORIESAUROBINDO PHARMA LTDMANKIND PHARMA LIMITEDLUPIN LIMITEDMANIPAL HEALTH ENTERPRI L
Compare Natural Biocon (India) Ltd with peers
Natural Biocon (India) Ltd vs SUN PHARMACEUTICAL IND LNatural Biocon (India) Ltd vs DIVI S LABORATORIES LTDNatural Biocon (India) Ltd vs TORRENT PHARMACEUTICALS LNatural Biocon (India) Ltd vs LAURUS LABS LIMITEDNatural Biocon (India) Ltd vs ZYDUS LIFESCIENCES LTDNatural Biocon (India) Ltd vs APOLLO HOSPITALS ENTER. L
Related tools & concepts
Value Natural Biocon (India) Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing